HEADER HYDROLASE/HYDROLASE INHIBITOR 06-OCT-09 3K4V TITLE NEW CRYSTAL FORM OF HIV-1 PROTEASE/SAQUINAVIR STRUCTURE REVEALS TITLE 2 CARBAMYLATION OF N-TERMINAL PROLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEASE; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HIV-1 PROTEASE; COMPND 10 CHAIN: C, D; COMPND 11 SYNONYM: PROTEASE; COMPND 12 EC: 3.4.23.16; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11678; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 11 ORGANISM_COMMON: HIV-1; SOURCE 12 ORGANISM_TAXID: 11678; SOURCE 13 GENE: GAG-POL; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX, CARBAMYLATION, AIDS, ASPARTYL KEYWDS 2 PROTEASE, CAPSID MATURATION, CAPSID PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR F.M.OLAJUYIGBE,N.DEMITRI,J.O.AJELE,E.MAURIZIO,L.RANDACCIO,S.GEREMIA REVDAT 6 06-SEP-23 3K4V 1 REMARK REVDAT 5 13-OCT-21 3K4V 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 HETSYN LINK REVDAT 4 24-SEP-14 3K4V 1 JRNL REVDAT 3 07-DEC-11 3K4V 1 JRNL REVDAT 2 13-JUL-11 3K4V 1 VERSN REVDAT 1 09-JUN-10 3K4V 0 JRNL AUTH F.M.OLAJUYIGBE,N.DEMITRI,J.O.AJELE,E.MAURIZIO,L.RANDACCIO, JRNL AUTH 2 S.GEREMIA JRNL TITL CARBAMYLATION OF N-TERMINAL PROLINE. JRNL REF ACS MED CHEM LETT V. 1 254 2010 JRNL REFN ISSN 1948-5875 JRNL PMID 24900204 JRNL DOI 10.1021/ML100046D REMARK 2 REMARK 2 RESOLUTION. 1.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.159 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.159 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3628 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 68870 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.149 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.144 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2863 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 53954 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3030 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 115 REMARK 3 SOLVENT ATOMS : 189 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3332.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 29 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 31932 REMARK 3 NUMBER OF RESTRAINTS : 42256 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 ANGLE DISTANCES (A) : 0.028 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.028 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.047 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.062 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.010 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.003 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.060 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.083 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) REMARK 4 REMARK 4 3K4V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000055548. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.2 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 72637 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.390 REMARK 200 RESOLUTION RANGE LOW (A) : 14.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.35400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2A1E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, DMSO, SODIUM REMARK 280 CITRATE, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.33650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 57 CD - NE - CZ ANGL. DEV. = 11.7 DEGREES REMARK 500 ARG B 8 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG C 57 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG C 87 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG C 87 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ARG D 41 NE - CZ - NH2 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG D 87 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG D 87 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR ROC IS A HYDROXYETHYLAMINE CONTAINING REMARK 600 TRANSITION STATE MIMETIC. REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: (2S)-N-[(2S,3R)-4-[(2S,3S,4AS,8AS)-3-(TERT- REMARK 630 BUTYLCARBAMOYL)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-1H-ISOQUINOLIN-2-YL]-3- REMARK 630 HYDROXY-1 -PHENYL-BUTAN-2-YL]-2-(QUINOLIN-2-YLCARBONYLAMINO) REMARK 630 BUTANEDIAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 ROC B 201 REMARK 630 ROC D 201 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: QNC ASN HP0 NTB REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROC B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS C 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROC D 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS D 901 REMARK 999 REMARK 999 SEQUENCE REMARK 999 CARBAMYLATION OF N-TERMINAL PROLINE DBREF 3K4V A 1 99 UNP P03366 POL_HV1B1 501 599 DBREF 3K4V B 1 99 UNP P03366 POL_HV1B1 501 599 DBREF 3K4V C 1 99 UNP P03366 POL_HV1B1 501 599 DBREF 3K4V D 1 99 UNP P03366 POL_HV1B1 501 599 SEQADV 3K4V ARF A 0 UNP P03366 SEE REMARK 999 SEQADV 3K4V LYS A 7 UNP P03366 GLN 507 ENGINEERED MUTATION SEQADV 3K4V ILE A 33 UNP P03366 LEU 533 ENGINEERED MUTATION SEQADV 3K4V ILE A 63 UNP P03366 LEU 563 ENGINEERED MUTATION SEQADV 3K4V ALA A 67 UNP P03366 CYS 567 ENGINEERED MUTATION SEQADV 3K4V ALA A 95 UNP P03366 CYS 595 ENGINEERED MUTATION SEQADV 3K4V ARF B 0 UNP P03366 SEE REMARK 999 SEQADV 3K4V LYS B 7 UNP P03366 GLN 507 ENGINEERED MUTATION SEQADV 3K4V ILE B 33 UNP P03366 LEU 533 ENGINEERED MUTATION SEQADV 3K4V ILE B 63 UNP P03366 LEU 563 ENGINEERED MUTATION SEQADV 3K4V ALA B 67 UNP P03366 CYS 567 ENGINEERED MUTATION SEQADV 3K4V ALA B 95 UNP P03366 CYS 595 ENGINEERED MUTATION SEQADV 3K4V LYS C 7 UNP P03366 GLN 507 ENGINEERED MUTATION SEQADV 3K4V ILE C 33 UNP P03366 LEU 533 ENGINEERED MUTATION SEQADV 3K4V ILE C 63 UNP P03366 LEU 563 ENGINEERED MUTATION SEQADV 3K4V ALA C 67 UNP P03366 CYS 567 ENGINEERED MUTATION SEQADV 3K4V ALA C 95 UNP P03366 CYS 595 ENGINEERED MUTATION SEQADV 3K4V LYS D 7 UNP P03366 GLN 507 ENGINEERED MUTATION SEQADV 3K4V ILE D 33 UNP P03366 LEU 533 ENGINEERED MUTATION SEQADV 3K4V ILE D 63 UNP P03366 LEU 563 ENGINEERED MUTATION SEQADV 3K4V ALA D 67 UNP P03366 CYS 567 ENGINEERED MUTATION SEQADV 3K4V ALA D 95 UNP P03366 CYS 595 ENGINEERED MUTATION SEQRES 1 A 100 ARF PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR SEQRES 2 A 100 ILE LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP SEQRES 3 A 100 THR GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU SEQRES 4 A 100 PRO GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY SEQRES 5 A 100 GLY PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE SEQRES 6 A 100 GLU ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL SEQRES 7 A 100 GLY PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU SEQRES 8 A 100 THR GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 100 ARF PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR SEQRES 2 B 100 ILE LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP SEQRES 3 B 100 THR GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU SEQRES 4 B 100 PRO GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY SEQRES 5 B 100 GLY PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE SEQRES 6 B 100 GLU ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL SEQRES 7 B 100 GLY PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU SEQRES 8 B 100 THR GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 C 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 C 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 C 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 C 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 C 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 C 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 C 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 C 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 D 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 D 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 D 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 D 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 D 99 GLN ILE GLY ALA THR LEU ASN PHE HET ARF A 0 3 HET ARF B 0 3 HET DMS A 901 4 HET DMS A 902 4 HET ROC B 201 98 HET CL B 202 1 HET DMS C 901 4 HET ROC D 201 98 HET DMS D 202 4 HETNAM ARF FORMAMIDE HETNAM DMS DIMETHYL SULFOXIDE HETNAM ROC (2S)-N-[(2S,3R)-4-[(2S,3S,4AS,8AS)-3-(TERT- HETNAM 2 ROC BUTYLCARBAMOYL)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-1H- HETNAM 3 ROC ISOQUINOLIN-2-YL]-3-HYDROXY-1 -PHENYL-BUTAN-2-YL]-2- HETNAM 4 ROC (QUINOLIN-2-YLCARBONYLAMINO)BUTANEDIAMIDE HETNAM CL CHLORIDE ION HETSYN ROC FORTOVASE; SAQUINAVIR; RO 31-8959 FORMUL 1 ARF 2(C H3 N O) FORMUL 5 DMS 4(C2 H6 O S) FORMUL 7 ROC 2(C38 H50 N6 O5) FORMUL 8 CL CL 1- FORMUL 12 HOH *189(H2 O) HELIX 1 1 GLY A 86 GLY A 94 1 9 HELIX 2 2 GLY B 86 GLY B 94 1 9 HELIX 3 3 GLY C 86 THR C 91 1 6 HELIX 4 4 GLY D 86 GLY D 94 1 9 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 A 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 TRP A 42 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O VAL A 56 N LYS A 45 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O VAL A 75 N TYR A 59 SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 LYS B 43 GLY B 49 0 SHEET 2 C 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 C 8 HIS B 69 VAL B 77 -1 O VAL B 75 N TYR B 59 SHEET 4 C 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 C 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 LEU B 10 ILE B 15 -1 N VAL B 11 O ALA B 22 SHEET 8 C 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 D 4 GLN C 2 ILE C 3 0 SHEET 2 D 4 THR D 96 ASN D 98 -1 O LEU D 97 N ILE C 3 SHEET 3 D 4 THR C 96 ASN C 98 -1 N ASN C 98 O THR D 96 SHEET 4 D 4 GLN D 2 ILE D 3 -1 O ILE D 3 N LEU C 97 SHEET 1 E 8 TRP C 42 GLY C 49 0 SHEET 2 E 8 GLY C 52 ILE C 66 -1 O GLN C 58 N LYS C 43 SHEET 3 E 8 HIS C 69 VAL C 77 -1 O VAL C 75 N TYR C 59 SHEET 4 E 8 VAL C 32 ILE C 33 1 N ILE C 33 O LEU C 76 SHEET 5 E 8 ILE C 84 ILE C 85 -1 O ILE C 84 N VAL C 32 SHEET 6 E 8 GLN C 18 LEU C 24 1 N LEU C 23 O ILE C 85 SHEET 7 E 8 LEU C 10 ILE C 15 -1 N ILE C 13 O LYS C 20 SHEET 8 E 8 GLY C 52 ILE C 66 -1 O GLU C 65 N LYS C 14 SHEET 1 F 8 TRP D 42 GLY D 49 0 SHEET 2 F 8 GLY D 52 ILE D 66 -1 O GLN D 58 N LYS D 43 SHEET 3 F 8 HIS D 69 VAL D 77 -1 O HIS D 69 N ILE D 66 SHEET 4 F 8 VAL D 32 ILE D 33 1 N ILE D 33 O LEU D 76 SHEET 5 F 8 ILE D 84 ILE D 85 -1 O ILE D 84 N VAL D 32 SHEET 6 F 8 GLN D 18 LEU D 24 1 N LEU D 23 O ILE D 85 SHEET 7 F 8 LEU D 10 ILE D 15 -1 N ILE D 13 O LYS D 20 SHEET 8 F 8 GLY D 52 ILE D 66 -1 O GLU D 65 N LYS D 14 LINK C ARF A 0 N PRO A 1 1555 1555 1.34 LINK C ARF B 0 N PRO B 1 1555 1555 1.32 SITE 1 AC1 7 LYS A 14 ILE A 15 GLY A 16 GLY A 17 SITE 2 AC1 7 ILE A 63 GLU A 65 GLY B 17 SITE 1 AC2 8 GLY A 17 DMS A 901 HOH A1038 LYS B 14 SITE 2 AC2 8 ILE B 15 GLY B 16 GLY B 17 ILE B 63 SITE 1 AC3 29 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 AC3 29 ASP A 29 ASP A 30 ILE A 47 GLY A 48 SITE 3 AC3 29 GLY A 49 ILE A 50 THR A 80 PRO A 81 SITE 4 AC3 29 VAL A 82 ILE A 84 HOH A1041 ARG B 8 SITE 5 AC3 29 ASP B 25 GLY B 27 ALA B 28 ASP B 29 SITE 6 AC3 29 ASP B 30 ILE B 47 GLY B 48 GLY B 49 SITE 7 AC3 29 ILE B 50 THR B 80 PRO B 81 ILE B 84 SITE 8 AC3 29 TRP C 6 SITE 1 AC4 1 SER B 37 SITE 1 AC5 3 LYS C 14 GLY C 17 ILE C 63 SITE 1 AC6 29 ARG C 8 LEU C 23 ASP C 25 GLY C 27 SITE 2 AC6 29 ALA C 28 ASP C 29 ASP C 30 ILE C 47 SITE 3 AC6 29 GLY C 48 ILE C 50 PRO C 81 ILE C 84 SITE 4 AC6 29 HOH C1001 ARG D 8 LEU D 23 ASP D 25 SITE 5 AC6 29 GLY D 27 ALA D 28 ASP D 29 ASP D 30 SITE 6 AC6 29 VAL D 32 GLY D 48 GLY D 49 ILE D 50 SITE 7 AC6 29 THR D 80 PRO D 81 VAL D 82 ILE D 84 SITE 8 AC6 29 HOH D1039 SITE 1 AC7 7 GLY C 17 DMS C 901 LYS D 14 ILE D 15 SITE 2 AC7 7 GLY D 16 GLY D 17 ILE D 63 CRYST1 51.205 62.673 59.076 90.00 98.42 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019529 0.000000 0.002891 0.00000 SCALE2 0.000000 0.015956 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017112 0.00000 HETATM 1 N ARF A 0 7.603 -6.462 39.178 1.00 40.29 N ANISOU 1 N ARF A 0 4650 5847 4810 -868 2394 -165 N HETATM 2 C ARF A 0 8.273 -6.766 38.074 1.00 33.01 C ANISOU 2 C ARF A 0 3352 4765 4424 60 1607 430 C HETATM 3 O ARF A 0 9.390 -7.311 38.054 1.00 34.94 O ANISOU 3 O ARF A 0 3621 4292 5362 245 1065 759 O